Navigation Links
Iomai Announces Year-End 2007 Financial Results and Business Progress
Date:3/6/2008

benefits of a major group of antigen-presenting cells found in the outer layers of the skin (Langerhans cells) to generate an enhanced immune response. Iomai is leveraging TCI to enhance the efficacy of existing vaccines, develop new vaccines that are viable only through transcutaneous administration and expand the global vaccine market. Iomai currently has four product candidates in development: three targeting influenza and pandemic flu and one to prevent travelers' diarrhea. For more information on Iomai, please visit http://www.iomai.com.

Some matters discussed in this press release constitute "forward-looking statements" that involve known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied by the forward-looking statements. Such forward-looking statements include statements about potential commercialization of a vaccine that could be mailed and self-applied, the ability of Iomai to enter into a partnering deal, conducting a Phase 3 trial of Iomai's travelers' diarrhea vaccine, and the sufficiency of existing cash and government contract revenues to fund operations into the third quarter of 2008. Applicable risks and uncertainties include, among others, that the clinical results may not support regulatory approval to commercialize any Iomai product candidate or the mailing and self-administration of any product that does gain approval, both of which will depend on the outcome of additional clinical trials and analysis by regulatory authorities of data Iomai submits; assessments by third-parties of the potential commercial value of the TCI technology, potential partners may determine to wait for additional clinical data prior to partnering or may be unwilling to partner on terms and conditions Iomai deems acceptable; Iomai's intellectual property position, and the market potential of Iomai's product candidates; future clinical trials may
'/>"/>

SOURCE Iomai Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Iomai to Announce Fourth Quarter and Year-End 2007 Financial Results and Host Webcast on Thursday, March 6
2. Iomai CEO to Speak at BIO CEO & Investor Forum on Feb. 12
3. Iomai to Announce Third Quarter 2007 Financial Results and Host Webcast on Tuesday, November 13
4. Iomai Chief Scientific Officer Dr. Gregory Glenn Details Development of Travelers Diarrhea Patch at Keystone Conference
5. Iomai CEO to Speak at Natixis Bleichroeder Hidden Gems Conference on Monday
6. Dragon announces new product launch; increase in annual production output capacity
7. Edwards Lifesciences Announces First Human Implants of Next-Generation Transcatheter Heart Valve
8. China Yingxia International Announces Q4 and FY 2007 Estimates
9. Bristol-Myers Squibb Announces Dividend
10. deCODE genetics Announces Webcast of Conference Call to Discuss Full-year 2007 Financial Results
11. Maxygen Announces Management Changes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... DUBLIN , July 11, 2014 ... in part) in, into or from any jurisdiction where to ... of such jurisdiction.  Shire plc ("Shire" or the ... Bloomberg article this afternoon.  Shire confirms it has held a ... being made by Shire without the prior agreement or approval ...
(Date:7/11/2014)...  Researchers have pioneered a revolutionary new way ... called Virtual Finger, allows scientists to move through ... synapses using the flat surface of their computer ... studies orders of magnitude more efficient, saving time, ... many areas of experimental biology. The software and ...
(Date:7/10/2014)... July 10, 2014 Understanding the need ... cell lines, and the gap that currently exists in ... expand its industry-leading portfolio of validated ion channel and ... channel-expressing cell lines, as ion channels control many critical ... this activity creates the potential to treat a variety ...
(Date:7/10/2014)... July 10, 2014 EvoDerma ’s NOOME ... This rejuvenating device now comes with a second treatment cup ... time. , The new cup is thinner on the edges ... to target rough, thin and uneven surfaces on the face, ... for a stimulating treatment on areas such as the cheeks ...
Breaking Biology Technology:Shire plc - Statement re: Media Speculation 2Virtual Finger Enables Scientists To Navigate And Analyze 3D Images Of Complex Biological Structures 2Virtual Finger Enables Scientists To Navigate And Analyze 3D Images Of Complex Biological Structures 3Leader in Ion Channel Research Announces Newly Validated and Re-Engineered Cells 2Leader in Ion Channel Research Announces Newly Validated and Re-Engineered Cells 3Introducing a New Bonus Treatment Cup for EvoDerma’s NOOME Anti-Aging Motion 2
... With all the domestic and global issues going on ... the world's leaders viewed issues in yesterday's critical moments. ... had to shoulder huge responsibilities. They are worth applying ... perspectives may help broaden your view of things. That's ...
... startup and spin-off companies are gaining attention from ... of this is Primorigen Biosciences LLC , ... analysis of cellular reprogramming and differentiation. , ,Primorigen, ... related products, will use a pair of investments ...
... Wis. - Norlight Telecommunications, Inc., which ... announced that it will roll out its new Voice ... businesses in Green Bay and Madison. , ,The ... growth market by offering integrated communications bundles of local ...
Cached Biology Technology:Business leaders can learn from historical insights 2Business leaders can learn from historical insights 3Business leaders can learn from historical insights 4Business leaders can learn from historical insights 5Wisconsin start up Primorigen Biosciences corrals out-of-state investment 2Norlight will offer VoIP in Madison, Green Bay 2
(Date:7/11/2014)... is evidence that under the normal circumstances, ... development, maintain neuronal environment, and exhibit therapeutic ... neurodegenerative disease. Previous studies have found that ... after chemical induction have reduced viability, which ... Prof. Xiaodong Yuan, Kailuan General Hospital, Hebei ...
(Date:7/11/2014)... Using spider toxins to study the proteins that let ... say they have stumbled upon a biological tactic that ... insect plagues in a safe and environmentally responsible way. ... be lethal for one species and harmless for a ... target specific pests without harming beneficial species like bees. ...
(Date:7/10/2014)... COLORADO SPRINGS, Colo. , June 27, 2014 ... announces that the National Institute of Standards and ... appointed 10 of its academic research and forensic ... Board (FSSB).  The Board is an element of ... These AAFS members are among the first appointments ...
Breaking Biology News(10 mins):Potent spider toxin 'electrocutes' German, not American, cockroaches 2Potent spider toxin 'electrocutes' German, not American, cockroaches 3Ten Members of the American Academy of Forensic Sciences Appointed to Forensic Science Standards Board (FSSB) 2Ten Members of the American Academy of Forensic Sciences Appointed to Forensic Science Standards Board (FSSB) 3
... state of chronic inflammation. If chronic, the inflammation will ... devastating disease multiple sclerosis, hyperactivity of immune cells called ... Researchers at BRIC, the University of Copenhagen, have identified ... combat such hyperactive T-cells in blood from patients with ...
... Lincoln, Neb., Feb. 17, 2014 -- Fertilizer could be too much ... findings to be published online Feb. 16 by the journal ... nitrogen will increase the amount of grass that can be grown. ... are better adapted to survive in harsher times. It results in ...
... why skeletal muscle stem cells stop dividing and renewing ... opportunity for managing muscle-wasting conditions in humans, says a ... to CU-Boulder Professor Bradley Olwin, the loss of skeletal ... to sarcopenia, a debilitating muscle-wasting condition that generally hits ...
Cached Biology News:New blood cells fight brain inflammation 2Worldwide study finds that fertilizer destabilizes grasslands 2CU-Boulder stem cell research may point to new ways of mitigating muscle loss 2CU-Boulder stem cell research may point to new ways of mitigating muscle loss 3
... protein assay reagents package is used for determining ... and detergents. The RC DC protein assay is ... for 500 standard assays: 250 ml RC reagent ... alkaline copper tartrate solution, 2 L dilute Folin ...
... SureLINK Bioconjugation Kit provides a powerful ... carbohydrates and nuceleic acids. The kit provides ... with reagents for quantifying conjugation efficiencies. It ... fluorophores, biotin and other tags with a ...
...
MAb to HLA, Class II-DR+DP Dry Ice: No Preservative: NaN3 Availability When Not in Inventory: 14-21 Business Days...
Biology Products: